Register entry
- Registered sites
- 1
- Active NDC listings
- 2
- Live patents
- 0
- Countries
- 1
- Base
- Egypt
Authorisation
Registered operations
Analytical testing1Labelling1Finished drug manufacture1Packaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Pharmaplast SAE | Beside Lord International Factory Building 30, Amria Free Zone, Alexandria, 23512, Egypt (EGY) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3003767891644773319 |
Catalogue
Drug listings by form and route
22 active NDC listings: 2 human otc drug. By marketing category: OTC MONOGRAPH DRUG 2.
| Dosage form | NDCs |
|---|---|
| patch | 1 |
| plaster | 1 |
| Route | NDCs |
|---|---|
| topical | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| pharmaplast sae | 2 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Cure-Aid Corn Plasters | Salicylic acid | patch, topical | 28691-4000OTC MONOGRAPH DRUG |
| Wart Remover | Salicylic Acid | plaster, topical | 28691-0400OTC MONOGRAPH DRUG |
Compare
Comparable companies in Egypt
- The Egyptian Saudi Co For Medical Manufacturing MascoMid1 site · 2 NDC
Enquiry
Common questions
- Is Pharmaplast SAE FDA approved?
- Pharmaplast SAE holds 1 FDA-registered establishment in Egypt. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Pharmaplast SAE's drugs manufactured?
- The FDA register lists Alexandria. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
- What drugs does Pharmaplast SAE make?
- 2 products are listed under Pharmaplast SAE in the openFDA NDC Directory, most often as patch; plaster. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.